Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has issued an update.
Syntara Limited has announced a new issuance of 44,028,744 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on February 20, 2025. This issuance is a part of previously announced transactions and reflects Syntara Limited’s strategic financial maneuvers to enhance its market presence and potentially fortify its capital structure, thus impacting its stakeholders and industry positioning.
More about Pharmaxis Ltd
YTD Price Performance: 7.50%
Average Trading Volume: 5,375,335
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$135.8M
For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.